抄録
We studied the clinical effectiveness and usefulness of Roxithromycin (Rulid®) in the treatment of odontogenic infection. Results obtained are summarized as follows: 1) Clinical efflcacy rates according to the doctor's subjective judgement were 89.4% in periodontitis, 92.9% in pericoronitis and 88.6 % in ostitis of jaw. The overall result was 90.1 %. 2) Clinical efficacy rates according to the committee judgement on the 3 rd day of treatment in 62 cases were 85.2 % in periodontitis, 87.5 % in pericoronitis and 73.7 % in ostitis of jaw. 3) Some side effects were observed in 4 cases (2.5 %) . No severe symptoms were observed. These results suggested that Roxithromycin is a useful antibacterial agent against odontogenic infections.
